Lantern Pharma, Inc. (LTRN)
3.60
-0.15
(-4.00%)
USD |
NASDAQ |
Jun 09, 12:55
Lantern Pharma Total Assets (Quarterly) : 7.223M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Replimune Group, Inc. | 333.59M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.777M |
| Shareholders Equity (Quarterly) | 3.446M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 1.868 |
| Net Debt Paydown Yield | 0.24% |